Literature DB >> 1390937

Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG.

M R Wilson1, S B Easterbrook-Smith.   

Abstract

Clusterin was purified from human serum by IgG and monoclonal antibody affinity chromatography. SDS-PAGE and immunoblotting revealed no major differences between clusterin prepared in these two ways. An ELISA method for measuring the binding of clusterin to immunoglobulins was developed. Clusterin purified by IgG affinity chromatography bound to pooled human IgG with a similar affinity (S0.5 5.9 +/- 0.4 micrograms/ml) as clusterin purified by monoclonal antibody chromatography (S0.5 6.1 +/- 0.2 micrograms/ml). The apparent affinity of clusterin for IgG immobilised on ELISA plates increased with increasing concentrations of IgG in the coating solution. Aggregated IgG in solution was a more potent inhibitor of the binding of clusterin to immobilised IgG than was monomer IgG. Clusterin bound to all of the isotypes of human IgG, and to human IgA and IgM, with apparent affinities in the order IgG3 > IgG4 > IgM > IgG1 > IgG2, IgA. Clusterin bound to both the Fab and Fc fragments of human IgG. The clusterin binding site(s) on the Fc do not overlap with those for protein A and Clq.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390937     DOI: 10.1016/0167-4838(92)90062-i

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Clusterin synergizes with IL-2 for the expansion and IFN-γ production of natural killer cells.

Authors:  Chung Hee Sonn; Young-Bin Yu; Young-Joo Hong; Young-Jun Shim; Jeffrey A Bluestone; Bon-Hong Min; Kyung-Mi Lee
Journal:  J Leukoc Biol       Date:  2010-08-20       Impact factor: 4.962

2.  Clusterin increases mitochondrial respiratory chain complex I activity and protects against hexavalent chromium-induced cytotoxicity in L-02 hepatocytes.

Authors:  Yuanyuan Xiao; Ming Zeng; Lirong Yin; Na Li; Fang Xiao
Journal:  Toxicol Res (Camb)       Date:  2018-11-15       Impact factor: 3.524

3.  Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry.

Authors:  Qingchun Zhang; Andrew M Goetze; Huanchun Cui; Jenna Wylie; Steve Trimble; Art Hewig; Gregory C Flynn
Journal:  MAbs       Date:  2014-02-11       Impact factor: 5.857

4.  Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.

Authors:  S R Partridge; M S Baker; M J Walker; M R Wilson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer.

Authors:  David Kevans; Sheeona Gorman; Miriam Tosetto; Kieran Sheahan; Diarmuid O'Donoghue; Hugh Mulcahy; Jacintha O'Sullivan
Journal:  J Gastrointest Cancer       Date:  2012-06

6.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

7.  Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing.

Authors:  Nicholas E Levy; Kristin N Valente; Leila H Choe; Kelvin H Lee; Abraham M Lenhoff
Journal:  Biotechnol Bioeng       Date:  2013-12-11       Impact factor: 4.530

8.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

9.  Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma.

Authors:  Fateme Tousi; Jonathan Bones; Othon Iliopoulos; William S Hancock; Marina Hincapie
Journal:  J Chromatogr A       Date:  2012-07-28       Impact factor: 4.759

10.  Structural characterization of clusterin-chaperone client protein complexes.

Authors:  Amy R Wyatt; Justin J Yerbury; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.